FDBusiness.com

Antimicrobial Resistance in Europe Remains High

 Breaking News
  • Lactalis Expands in Infant Nutrition With €740 Million Acquisition Lactalis Group, the international dairy group based in Laval, France, is acquiring the Nutritional business of Aspen Pharmacare for €739.8 million (R12.9 billion). The business being acquired supplies a wide range of infant nutritional and growing-up milk products across both the premium and value segments. It manufactures and markets well established quality brands, including S-26, [...]...
  • Thatchers Cider to Invest £14 Million in New Cider Mill Thatchers Cider, the family owned English cider producer, is to invest £14 million in a new cider mill at its Myrtle Farm site in Somerset to meet growing demand for its products. The company has applied for planning permission and, if granted, the new mill would come on stream in 2019. “This investment is about our [...]...
  • Coca-Cola Great Britain Teams Up With Premier League Premier League and Coca-Cola Great Britain have announced a new three-and-a-half-year partnership, starting in January 2019. It is the first sponsorship Coca-Cola Great Britain will activate across multiple brands within its portfolio, showcasing a range of drinks including sparkling soft drinks, water and fruit-based drinks, with low and no-sugar options. The partnership will see Coca-Cola work [...]...
  • Barry Callebaut Completes $30 Million Capacity Expansion in North America Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa products, has announced the completion of several expansion investments in three of its North American facilities located in St Hyacinthe, Quebec; Chatham, Ontario; and St Albans, Vermont. The investments amount to close to US$30 million and are in line with previously announced plans. Recent investments [...]...
  • Strong First Half From Hilton Food Group Hilton Food Group, the UK-based leading specialist international food packing business, has reported a 25.0% increase in turnover to £863.6 million and by 24.5% on a constant currency basis for the 28 weeks to 15 July 2018. Volumes increased by 12.7% reflecting growth in the UK, Ireland and Australia. Operating profit for the first half [...]...

Antimicrobial Resistance in Europe Remains High

Antimicrobial Resistance in Europe Remains High
February 27
09:28 2017

Bacteria found in humans, animals and food continue to show resistance to widely used antimicrobials, says the latest report on antimicrobial resistance (AMR) in bacteria by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC). The findings underline that AMR poses a serious threat to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25,000 deaths in the EU every year.

Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, says: “Antimicrobial resistance is an alarming threat putting human and animal health in danger. We have put substantial efforts to stop its rise, but this is not enough. We must be quicker, stronger and act on several fronts. This is why the Commission will launch a new Action Plan this summer that will give a new framework for future coordinated actions to reduce the spread of antimicrobial resistance.”

The report shows that in general multi-drug resistance in Salmonella bacteria is high across the EU. However, experts note that resistance to critically important antimicrobials used to treat severe human cases of Salmonella infection remains low. Salmonellosis, the disease caused by these bacteria, is the second most commonly reported foodborne disease in the EU.

Mike Catchpole, Chief Scientist at ECDC, says: “It is of particular concern that some common types of Salmonella in humans, such as monophasic Salmonella Typhimurium, exhibit extremely high multi-drug resistance. Prudent use of antibiotics in human and veterinary medicine is extremely important to address the challenge posed by antimicrobial resistance. We all have a responsibility to ensure that antibiotics keep working.”

The report also highlights that antimicrobial resistance levels in Europe continue to vary by geographical region, with countries in Northern and Western Europe generally having lower resistance levels than those in Southern and Eastern Europe. Marta Hugas, Head of EFSA’s Biological Hazards and Contaminants unit, says: “These geographic variations are most likely related to differences in antimicrobial use across the EU. For example, countries where actions have been taken to reduce, replace and re-think the use of antimicrobials in animals show lower levels of antimicrobial resistance and decreasing trends.”

This year, the publication of the report is accompanied by a data visualisation tool, which displays data by country on antimicrobial resistance levels of some bacteria found in foods, animals and humans.

Explore the data: Antimicrobial resistance in Europe

The report also includes the following findings that may have a public health impact:

* Resistance to carbapenem antibiotics has been detected for the first time as part of EU-wide annual monitoring in animals and food. Carbapenems are usually the last remaining treatment option for patients infected with multi-drug resistant bacteria to other available antibiotics. Very low levels of resistance were observed in E. coli bacteria found in pigs and meat from pigs.

* Extended-spectrum beta-lactamase (ESBL)-producing E. coli has been detected in beef, pork, pigs and calves. Bacteria that produce ESBL enzymes show multi-drug resistance to β-lactam antibiotics, which include penicillin derivatives and cephalosporins. The prevalence of ESBL-producing E. coli varied across countries, from low to very high (find out more from our data visualisation tool).

* Resistance to colistin has been found at very low levels in Salmonella and E. coli in pigs and cattle. Colistin may be commonly used in some countries for the control of infections in animals, especially in pigs. In some circumstances it may be used as a last-resort antibiotic in humans.

* More than 10% of the tested Campylobacter coli bacteria in humans showed resistance to two critically important antimicrobials (fluoroquinolones and macrolides), which are used to treat severe cases of Campylobacter infections in humans. Campylobacteriosis is the most commonly reported foodborne disease in the EU.

Scientific Report: The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 25, 2018PPMA Show 2018
  • September 27, 2018Int'l Fruit Show (eurofruit)
  • September 30, 2018Trade Fair for Butchers, Caterers and Meat Industry (Meat Expo)
  • October 1, 2018Poznan International Fair
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements